Insider: Ullem Scott B. CVP, Chief Financial Officer - Edwards Lifesciences Corp
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 41,098 | 0 | 41,098 |
| Value | $3,137,306.25 | $0.00 | $3,137,306.25 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/09/2025 | DDS | 11,250 | Direct | COM | $74.40 | $837,034.88 | 41,098 |
| 03/26/2025 | DDS | 11,250 | Direct | COM | $70.87 | $797,267.25 | 30,387 |
| 02/13/2025 | DDS | 11,250 | Direct | COM | $75.76 | $852,271.88 | 30,561 |
| 12/09/2024 | DDS | 11,250 | Direct | COM | $71.68 | $806,405.63 | 30,561 |
| 06/20/2024 | DDS | 400 | Direct | COM | $88.11 | $35,245.00 | 35,786 |
| 06/20/2024 | DDS | 5,225 | Direct | COM | $87.47 | $457,012.99 | 30,561 |
| 05/21/2024 | DDS | 5,625 | Direct | COM | $90.45 | $508,803.19 | 30,561 |
| 04/30/2024 | DDS | 700 | Direct | COM | $86.40 | $60,482.52 | 25,624 |
| 04/30/2024 | DDS | 6,550 | Direct | COM | $85.74 | $561,579.32 | 19,074 |
| 04/01/2024 | DDS | 868 | Direct | COM | $95.51 | $82,902.68 | 25,461 |
| 04/01/2024 | DDS | 6,387 | Direct | COM | $94.81 | $605,520.81 | 19,074 |
| 02/29/2024 | DDS | 7,255 | Direct | COM | $85.59 | $620,922.80 | 19,074 |
| 02/01/2024 | DDS | 7,255 | Direct | COM | $78.29 | $567,993.95 | 19,248 |
| 12/29/2023 | DDS | 14,510 | Direct | COM | $76.55 | $1,110,794.19 | 19,248 |
| 10/31/2023 | DDS | 7,255 | Direct | COM | $62.66 | $454,568.55 | 19,248 |
| 09/29/2023 | DDS | 7,255 | Direct | COM | $69.54 | $504,527.21 | 19,248 |
| 08/31/2023 | DDS | 7,255 | Direct | COM | $77.79 | $564,366.45 | 19,248 |
| 07/31/2023 | DDS | 7,255 | Direct | COM | $84.35 | $611,959.25 | 19,248 |
| 06/30/2023 | DDS | 7,255 | Direct | COM | $93.27 | $676,673.85 | 19,248 |
| 05/10/2023 | DDS | 64,119 | Direct | COM | $88.36 | $5,665,618.96 | 18,294 |
| 05/10/2023 | DDS | 16,581 | Direct | COM | $89.22 | $1,479,385.01 | 82,413 |
| 10/26/2020 | DDS | 13,921 | Direct | COM | $78.26 | $1,089,400.38 | 46,343 |
| 10/26/2020 | DDS | 19,229 | Direct | COM | $79.20 | $1,522,988.72 | 27,114 |
| 10/12/2020 | DDS | 5,650 | Direct | COM | $84.37 | $476,672.99 | 54,614 |
| 10/12/2020 | DDS | 27,500 | Direct | COM | $83.69 | $2,301,543.75 | 27,114 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research